BioLineRx (BLRX) Non-cash Items (2013 - 2026)

BioLineRx's Non-cash Items history runs 13 years deep, the most recent figure standing at -$964000.0 for Q4 2025.

• In Q4 2025, Non-cash Items rose 82.22% year-over-year to -$964000.0; the TTM figure through Dec 2025 stood at -$6.0 million (up 82.55% YoY), while the FY2025 annual figure was -$6.0 million, up 82.55% from the prior year.
• Non-cash Items for Q4 2025 stood at -$964000.0, down from $228000.0 in the prior quarter.
• The five-year high for Non-cash Items was $18.9 million in Q4 2023, with the low at -$22.0 million in Q3 2024.
• The 5-year median for Non-cash Items is $107000.0 (2022), against an average of -$25100.0.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items soared 39222.92% in 2023, then plunged 503.47% in 2024.
• BioLineRx's Non-cash Items stood at -$1.2 million in 2021, then jumped by 104.0% to $48000.0 in 2022, then jumped by 39222.92% to $18.9 million in 2023, then slumped by 128.73% to -$5.4 million in 2024, then soared by 82.22% to -$964000.0 in 2025.
• Business Quant data shows BLRX's Non-cash Items at -$964000.0 in Q4 2025, $228000.0 in Q3 2025, and $2.4 million in Q2 2025.